J. R. Scranton

Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer

Corey J. Langer, Silvia Novello, Keunchil Park et al. · Journal of Clinical Oncology · 2014 · 181 citations · Full text

Medicine, Oncology, Pharmacology +17

Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non–Small Cell Lung Cancer: Independent Review of Four PROFILE Trials

Ken Y. Yoneda, J. R. Scranton, Michael A. Cadogan et al. · Clinical Lung Cancer · 2017 · 55 citations

Medicine, Oncology, Pharmacology +15

Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono, Josep M. Piulats, Hardev Pandha et al. · Clinical Cancer Research · 2014 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

The Kinetics of the Inhibition of Thyroidal Iodide Accumulation by Thiocyanate: A Reexamination

J. R. Scranton, W. M. NlSSEN, N. S. Halmi · Endocrinology · 1969 · 23 citations

Medicine, Endocrinology, Pharmacology +14

Thyroidal Iodide Accumulation and Loss<i>in Vitro</i>

J. R. Scranton, N. S. Halmi · Endocrinology · 1965 · 13 citations

Medicine, Endocrinology, Endocrine Nuclear Medicine +13